Contact this trialFirst, we need to learn more about you.
Small Molecule
DNL343 for Amyotrophic Lateral Sclerosis
Recruiting0 awardsPhase 1
Charlotte, North Carolina
This trial is testing a new drug for safety, how it is processed by the body, and how it affects people with ALS.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.